Antibodies are classified as the primary class of therapeutics, due largely for their capability to connect with unique ligand conformations as a way to elicit distinct biological responses. Even so, discovery of latest molecules binding certain epitopes is time-consuming and demanding, especially for circumstances requiring a selected antibody-lig